The stock was down 6.5% in after-hours trading, though, because CrowdStrike said it expects first-quarter earnings to be ...

Outlook Therapeutics (NASDAQ:OTLK), a biopharmaceutical company that focuses on retinal diseases saw its stock price upped 18.24% on Friday after its financial results for fiscal years 2024 ...

Palo Alto Networks posted a 20% increase in fiscal first-quarter revenue as demand for cybersecurity products remains strong. But concerns about the company's outlook weighed the cybersecurity ...

Stock could start looking ‘attractive’ once the ‘mid-cycle’ outlook sinks in with investors, analyst says Last Updated: Nov. 22, 2023 at 10:47 a.m. ET First Published: Nov. 22, 2023 at 6: ...